Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care (integrated buprenorphine treatment) is an evidence-informed intervention to safely reduce opioid use disorder and improve HIV health outcomes among people with HIV. In collaboration with HIV experts and community members, E2i adapted integrated buprenorphine treatment for the Ryan White HIV/AIDS Program (RWHAP) and produced a toolkit that provides the resources needed to implement integrated buprenorphine treatment within RWHAP settings and other HIV care organizations. Algunos recursos están disponibles en español.
Integrated Buprenorphine Treatment: E2i Toolkit
Please note: The content of this website is frozen as of 6/30/2025 and logins are disabled. UCSF has chosen to keep the site’s resources available until HAB announces the results of the new cooperative agreement competition. We will be monitoring the site for security issues but will not be available to add or remove any content or to respond to questions.